Abrdn Life Sciences Investors (HQL)

Abrdn Life Sciences Investors is a closed-end fund (Healthcare) sponsored by abrdn. As of the 2026-11-09 close it traded at $18.66 against a net asset value of $19.46, a discount of -4.11%. Its one-year average was -8.62% and its one-year discount z-score is 1.89.

Distribution rate: +12.00% on price, +11.51% on NAV.

All closed-end funds and BDCs · Activist campaigns · Discount trends